Formation of Pentosidine During Nonenzymatic Browning of Proteins by Glucose Daniel G
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Protein Crosslinking by the Maillard Reaction With
PROTEIN CROSSLINKING BY THE MAILLARD REACTION WITH ASCORBIC ACID AND GLUCOSE by ZHENYU DAI Submitted in partial fulfillment of the requirements for the Degree of Doctor of Philosophy Dissertation Advisor: Vincent M. Monnier, M. D. Department of Biochemistry CASE WESTERN RESERVE UNIVERSITY August 2007 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the dissertation of ______________________________________________________ candidate for the Ph.D. degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. Table of Contents List of Tables……………………………………………………………………………2 List of Figures…………………………………………………………………………..3 Acknowledgements……………………………………………………………………..6 List of Abbreviations…………………………………………………………………....7 Abstract………………………………………………………………………………...10 Chapter 1. Introduction……………………………………………………………….. 12 Chapter 2. Histidino-threosidine: A novel crosslink from ascorbic acid degradation products Introduction…………………………………………………………………..49 Experimental Procedures…………………………………………………….50 Results………………………………………………………………………..55 Discussion……………………………………………………………………72 Chapter 3. Glucosepane: Site-specific crosslinking -
Review the ROLE of ADVANCED GLYCATION END PRODUCTS IN
CELLULAR & MOLECULAR BIOLOGY LETTERS http://www.cmbl.org.pl Received: 31 December 2013 Volume 19 (2014) pp 407-437 Final form accepted: 28 July 2014 DOI: 10.2478/s11658-014-0205-5 Published online: August 2014 © 2014 by the University of Wrocław, Poland Review THE ROLE OF ADVANCED GLYCATION END PRODUCTS IN VARIOUS TYPES OF NEURODEGENERATIVE DISEASE: A THERAPEUTIC APPROACH PARVEEN SALAHUDDIN1, GULAM RABBANI2 and RIZWAN HASAN KHAN2, * 1Distributed Information Sub Center, 2Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh 202 002, India Abstract: Protein glycation is initiated by a nucleophilic addition reaction between the free amino group from a protein, lipid or nucleic acid and the carbonyl group of a reducing sugar. This reaction forms a reversible Schiff base, which rearranges over a period of days to produce ketoamine or Amadori products. The Amadori products undergo dehydration and rearrangements and develop a cross-link between adjacent proteins, giving rise to protein aggregation or advanced glycation end products (AGEs). A number of studies * Author for correspondence. Email: [email protected], [email protected], phone: +91-571-2721776 Abbreviations used: A – amyloid beta; AD – Alzheimer’s disease; AFGPs – alkylformyl glycosylpyrroles; AG – aminoguanidne; AGEs – advanced glycation end products; AKR – aldo-keto-reductase; ALI – arginine lysine imidazole; ALS – amylolateral sclerosis; ALT – 711alagebrium chloride; APP – amyloid precursor protein; BSE – bovine spongiform encelopathy; CD-36 – cluster -
Comparative Study on the Status of Glycation Precursors, Advanced
Journal of Young Investigators RESEARCH ARTICLE Comparative Study on the Status of Glycation Precursors, Advanced Glycation End Products, and Cell Viability Under Effects of Kaempferol, Myricetin, and Azaleatin in HGC-27 Cell Line Fargol Mashhadi Akbar Boojar1*, Sepideh Golmohamad2, Golnaz Tafreshi3 Glycation as an endogenous process may alter the structure and biological functions of macromolecules, thus playing an im- portant role in cell growth retardation. This study was conducted to evaluate the levels of glycation precursors, advanced glyca- tion end products, and cell viability under effects of kaempferol, myricetin, and azaleatin in the HGC-27 cell line. Results showed that each compound had significant inhibitory effect on cell growth at concentrations of 20 µmol and higher, in which kaempfer- ol, myricetin and azaleatin were more effective respectively. Moreover, we had markedly elevated pentosidine content of cells treated with kaempferol, azaleatin and then myricetin in comparison with the control. Kaempferol, myricetin, and azaleatin were more effective, respectively, when 3-deoxyglucoson was increased in a dose-dependent manner Azaleatin caused signifi- cantly increased methylglyoxal content, reaching approximately 3.3 folds higher than the control. However, this parameter varied slightly for myricetin and kaempferol-treated cells for all treatment concentrations. Accordingly, the chemopreventive proper- ties of our flavonoides may be attributed to increasing in advanced glycation end products and glycation precursors within treated cells. Moreover, the structural characteristics of these compounds may contribute to their different anticancer activities in this study. INTRODUCTION rosis, and Alzheimer’s Disease (Hartog et al., 2007; Reddy and Glycation, a non-enzymatic glycosylation by glucose and other Obrenovich, 2002). -
Carbonyl Stress in Red Blood Cells and Hemoglobin
antioxidants Review Carbonyl Stress in Red Blood Cells and Hemoglobin Olga V. Kosmachevskaya 1, Natalia N. Novikova 2 and Alexey F. Topunov 1,* 1 Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, 119071 Moscow, Russia; [email protected] 2 National Research Center “Kurchatov Institute”, 123182 Moscow, Russia; [email protected] * Correspondence: [email protected]; Tel.: +7-916-157-6367 Abstract: The paper overviews the peculiarities of carbonyl stress in nucleus-free mammal red blood cells (RBCs). Some functional features of RBCs make them exceptionally susceptible to reactive carbonyl compounds (RCC) from both blood plasma and the intracellular environment. In the first case, these compounds arise from the increased concentrations of glucose or ketone bodies in blood plasma, and in the second—from a misbalance in the glycolysis regulation. RBCs are normally exposed to RCC—methylglyoxal (MG), triglycerides—in blood plasma of diabetes patients. MG modifies lipoproteins and membrane proteins of RBCs and endothelial cells both on its own and with reactive oxygen species (ROS). Together, these phenomena may lead to arterial hypertension, atherosclerosis, hemolytic anemia, vascular occlusion, local ischemia, and hypercoagulation pheno- type formation. ROS, reactive nitrogen species (RNS), and RCC might also damage hemoglobin (Hb), the most common protein in the RBC cytoplasm. It was Hb with which non-enzymatic glycation was first shown in living systems under physiological conditions. Glycated HbA1c is used as a very reliable and useful diagnostic marker. Studying the impacts of MG, ROS, and RNS on the physiological state of RBCs and Hb is of undisputed importance for basic and applied science. -
Development and Evaluation of Novel ELISA for Determination of Urinary Pentosidine
J Nutr Sci Vitaminol, 65, 526–533, 2019 Development and Evaluation of Novel ELISA for Determination of Urinary Pentosidine Shoji KASHIWABARA1, Hiroaki HOSOE1, Rei-ichi OHNO2, Ryoji NAGAI2 and Masataka SHIRAKI3 1 Research & Development, SB Bioscience Co., Ltd., 33–94 Enoki-cho, Suita, Osaka 564–0053, Japan 2 Laboratory of Food and Regulation Biology, Graduate School of Agriculture, Tokai University, Toroku 9–1–1, Higashi-ku, Kumamoto, Kumamoto 862–8652, Japan 3 Research Institute and Practice for Involutional Diseases, Nagano 399–8101, Japan (Received June 12, 2019) Summary Pentosidine is the most well-characterized advanced glycation end product (AGE). It has been measured by HPLC, although this approach cannot be adapted to analyze many clinical samples and is also time-consuming. Furthermore, the detection of pentosi- dine using a reported ELISA kit and HPLC system requires pretreatment by heating, which generates artificial pentosidine leading to overestimation. We developed a novel pentosidine ELISA system that don’t require sample pretreatment for analyzing urine samples. We then analyzed the accuracy, precision, and reliability of this system. Urinary samples for analysis were obtained from healthy volunteers and stored urinary samples from the participants of the Nagano cohort study were also used. The LoB and LoD were 4.25 and 6.24 pmol/mL, respectively. Intra- and inter-assay coefficients of variation were less than 5%. The spiking and dilution recoveries were 101.4% and 100.5%, respectively. Analysis of the cross-reac- tivities against seven compounds representative of AGEs and structurally similar to pento- sidine showed no significant cross-reactivity. The correlation coefficient between the con- centrations of pentosidine obtained from HPLC and ELISA for the same urine samples was r50.815. -
Polyphenols with Antiglycation Activity and Mechanisms of Action: a Review of Recent findings
journal of food and drug analysis xxx (2016) 1e9 Available online at www.sciencedirect.com ScienceDirect journal homepage: www.jfda-online.com Review Article Polyphenols with antiglycation activity and mechanisms of action: A review of recent findings * Wan-Ju Yeh a,1, Shih-Min Hsia a,1, Wei-Hwa Lee b,1, Chi-Hao Wu a,c, a School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan b Department of Pathology, Taipei Medical University-Shuang Ho Hospital, Taipei, Taiwan c Nutrition Research Centre, Taipei Medical University Hospital, Taipei, Taiwan article info abstract Article history: Advanced glycation end products (AGEs) are substances composed of amino groups of Received 23 September 2016 proteins and reducing sugars. The initial and propagation phases of the glycation process Received in revised form are accompanied by the production of a large amount of free radicals, carbonyl species, and 6 October 2016 reactive dicarbonyl species, of which, methylglyoxal (MG) is the most reactive and can Accepted 12 October 2016 cause dicarbonyl stress, influencing normal physiological functions. In the advanced Available online xxx phase, the production of AGEs and the interaction between AGEs and their receptor, RAGE, are also considered to be among the causes of chronic diseases, oxidative stress, and in- Keywords: flammatory reaction. Till date, multiple physiological activities of polyphenols have been advanced glycation end products confirmed. Recently, there have been many studies discussing the ability of polyphenols to antiglycation suppress the MG and AGEs formation, which was also confirmed in some in vivo studies. flavonoid This review article collects recent literatures concerning the effects of polyphenols on the phenolic acid generation of MG and AGEs through different pathways and discusses the feasibility of the polyphenols inhibition of glycative stress and dicarbonyl stress by polyphenols. -
Sustainable Synthesis of Thioimidazoles Via Carbohydrate-Based Multicomponent Reactions Marcus Baumann and Ian R
Letter pubs.acs.org/OrgLett Sustainable Synthesis of Thioimidazoles via Carbohydrate-Based Multicomponent Reactions Marcus Baumann and Ian R. Baxendale* Department of Chemistry, Durham University, South Road, Durham, DH1 3LE, United Kingdom *S Supporting Information ABSTRACT: The synthesis of diversely functionalized thioimida- zoles through a modern variant of the Marckwald reaction is presented. This new protocol utilizes unprotected carbohydrates as well as simple amine salts as sustainable and biorenewable starting materials. Importantly it was discovered that a bifurcated reaction pathway results from using aldoses and ketoses respectively, yielding distinct reaction products in a highly selective manner. ulticomponent reactions represent some of the most Scheme 1. Representative Imidazole-Forming M versatile chemical transformations converting three or Multicomponent Reactions more simple starting materials into a complex molecule in a single cascade.1 As such, these reactions continue to play a pivotal role in the assembly of complex molecular architectures for both natural product and medicinal chemistry programs.2 Despite the structural diversity resulting from these atom- and step-economical reactions,3 sourcing the appropriately prefunctionalized substrates can be cumbersome as this commonly adds extra steps to the final synthetic route. We therefore sought to address this generic problem by making use of diverse yet highly abundant biorenewable starting materials such as carbohydrates and amino acid derivatives.4 We reasoned -
The Maillard Reaction in Food and Medicine
COST - IMARS Joint Workshop Cost Action 927 - IMARS The Maillard Reaction in Food and Medicine Napoli, 2006 May 24-27 Centro Congressi Ateneo Federico II Via Partenope, 36 - Napoli Wednesday, May 24 13.30: Registration 14.00-18.00: “APPETIZER WORKSHOP” Three moderated debates about the question: “Are dietary AGEs/ALEs a risk to human health and, if they are, what is the mechanism of action?” Motion 1: Dietary AGEs are a risk to human health Chair: Thomas Henle For the motion: Katerina Sebekova Against the motion: Jenny Ames Motion 2: Dietary ALEs are a risk to human health Chair: Vincent Monnier For the motion: Joseph Kanner Against the motion: John Baynes Coffee break Motion 3: The mechanism by which dietary AGEs and ALEs pose a risk to human health is via their interaction with RAGE Chair: Paul Thornalley For the motion: Anne-Marie Schmidt Against the motion: Claus Heizmann Wednesday, May 24 COST927-IMARS WORKSHOP THE MAILLARD REACTION IN FOOD AND MEDICINE 18.15-19.15 Welcome addresses IMARS President: Vincent Monnier COST action 927 Chair: Vincenzo Fogliano Opening lecture: Helmut Erbersdobler Forty years of Furosine - Forty years of using markers for Maillard Reaction in Food and Nutrition Thursday, May 25 8.30: Registration 9.00-12.30: Exogenous and endogenous MRPs/AGEs: nutrition and toxicology Chairs: Karl Heinz Wagner & Veronika Somoza 9.00 T. Henle: Antimicrobial and cytotoxic effects of dicarbonyl compounds in honey - risk or benefit? 9.25 J. Ames: Effect of dietary heat treatment on the profile of human colonic bacteria in ulcerative colitis: in vitro and in vivo studies 9.50 T. -
Dietary Advanced Glycation Endproducts and the Gastrointestinal Tract
nutrients Review Dietary Advanced Glycation Endproducts and the Gastrointestinal Tract Timme van der Lugt 1,2,* , Antoon Opperhuizen 1,2, Aalt Bast 1,3 and Misha F. Vrolijk 3 1 Department of Pharmacology and Toxicology, Maastricht University, 6229 ER Maastricht, The Netherlands; [email protected] 2 Office for Risk Assessment and Research, Netherlands Food and Consumer Product Safety Authority (NVWA), 3540 AA Utrecht, The Netherlands 3 Campus Venlo, Maastricht University, 5911 BV Venlo, The Netherlands; [email protected] (A.B.); [email protected] (M.F.V.) * Correspondence: [email protected] Received: 27 August 2020; Accepted: 11 September 2020; Published: 14 September 2020 Abstract: The prevalence of inflammatory bowel diseases (IBD) is increasing in the world. The introduction of the Western diet has been suggested as a potential explanation of increased prevalence. The Western diet includes highly processed food products, and often include thermal treatment. During thermal treatment, the Maillard reaction can occur, leading to the formation of dietary advanced glycation endproducts (dAGEs). In this review, different biological effects of dAGEs are discussed, including their digestion, absorption, formation, and degradation in the gastrointestinal tract, with an emphasis on their pro-inflammatory effects. In addition, potential mechanisms in the inflammatory effects of dAGEs are discussed. This review also specifically elaborates on the involvement of the effects of dAGEs in IBD and focuses on evidence regarding the involvement of dAGEs in the symptoms of IBD. Finally, knowledge gaps that still need to be filled are identified. Keywords: inflammatory bowel disease; dietary advanced glycation endproducts; gastrointestinal tract; inflammation; digestion 1. -
The Mechanisms of Inhibition of Advanced Glycation End Products Formation Through Polyphenols in Hyperglycemic Condition
32 Reviews The Mechanisms of Inhibition of Advanced Glycation End Products Formation through Polyphenols in Hyperglycemic Condition Authors Shahpour Khangholi1, Fadzilah Adibah Abdul Majid1, 2, Najat Jabbar Ahmed Berwary3, Farediah Ahmad4, Ramlan Bin Abd Aziz 2 Affiliations 1 Tissue Culture Engineering Laboratory, Universiti Teknologi Malaysia (UTM), Malaysia 2 Institute of Bio-products Development, Universiti Teknologi Malaysia (UTM), Malaysia 3 College of Medicine, Hawler Medical University, Erbil, Iraq 4 Department of Biochemistry, Faculty of Sciences, Universiti Teknologi Malaysia (UTM), Malaysia Key words Abstract the action mechanisms of the components of l" AGEs ! polyphenols. l" diabetic complications Glycation, the non-enzymatic binding of glucose l" polyphenols to free amino groups of an amino acid, yields irre- l" antiglycation versible heterogeneous compounds known as ad- Abbreviations l" hyperglycemia ! l" antioxidant vanced glycation end products. Those products play a significant role in diabetic complications. ALEs: advanced lipoxidation end products In the present article we briefly discuss the con- AGEs: advanced glycation end products tribution of advanced glycation end products to AR: aldose reductase the pathogenesis of diabetic complications, such CML: carboxymethyllysine as atherosclerosis, diabetic retinopathy, nephrop- EGCG: epigallocatechin-3-gallate athy, neuropathy, and wound healing. Then we GLUT-4: glucose transporter type 4 mention the various mechanisms by which poly- GO: glyoxal phenols inhibit the formation -
Formation and Inhibition of Advanced Glycation Endproducts in Meat and Model Systems
FORMATION AND INHIBITION OF ADVANCED GLYCATION ENDPRODUCTS IN MEAT AND MODEL SYSTEMS by GENGJUN CHEN B.S., China Agricultural University, 2006 M.S., Beijing Technology and Business University, 2009 AN ABSTRACT OF A DISSERTATION submitted in partial fulfillment of the requirements for the degree DOCTOR OF PHILOSOPHY Food Science KANSAS STATE UNIVERSITY Manhattan, Kansas 2016 Abstract Advanced glycation endproducts (AGEs) are formed in many cooked meat products via Maillard browning reactions. Current research suggests consumption of these compounds may be a contributor to chronic diseases such as diabetes and heart diseases. Thus, information on the prevalence and inhibition of these compounds in food is desirable. The first objective was to determine the AGE content, as determined as Nε- carboxymethyllysine (CML) level, in cooked meat and fish prepared by general cooking methods recommended by U.S. Department of Agriculture, Food Safety and Inspection Service (USDA- FSIS). We found AGE was detected in all the cooked samples, but the levels depended on the different cooking conditions. Broiling and frying at higher cooking temperatures produced higher levels of CML and broiled beef contained the highest CML content (21.84 μg/g). However, the baked salmon (8.59 μg/g) and baked tilapia (9.72 μg/g) contained less CML as compared to the other samples. In order to investigate the inhibitory effect of selected natural antioxidant on AGEs formation in cooked meat, four cereal brans, wheat (Jagger, JA), triticale (Spring Triticale, ST; Thundercale, TH), and Rye (RY) bran were added to beef patties before cooking. RY (42.0% inhibition), ST (27.5% inhibition), and TH (21.4% inhibition) brans significantly decreased CML formation compared with the control. -
(12) United States Patent (10) Patent No.: US 8,501,838 B2 Jackson Et Al
USOO8501838B2 (12) United States Patent (10) Patent No.: US 8,501,838 B2 Jackson et al. (45) Date of Patent: Aug. 6, 2013 (54) COMPOSITE WOOD BOARD 1,886,353 A 1 1/1932 Novotny et al. 2,198,874 A 4, 1940 Holmes (75) Inventors: RE so St. E. Tony 2,392,1052,215,825 A 9,1/1946 1940 WallaceSussman indow, St. Helens (GB); George 2,442,989 A 6/1948 Sussman Baybutt, St. Helens (GB) 2,518,956 A 8/1950 Sussman 2,875,073. A 2/1959 Gogek (73) Assignee: Knauf Insulation SPRL (BE) 3,232,821 A 2f1966 Moore et al. 3,297,419 A * 1/1967 Eyre, Jr. .......................... 44,534 (*)c Notice:- r Subject to any distic the t 3,791,8073,513,001 A 2,5/1970 1974 WorthingtonEtzel et al. patent is extended or adjusted under 35 3,802,897 A 4/1974 Voigt et al. U.S.C. 154(b) by 235 days. 3,809,664 A 5, 1974 Fanta 3,826,767 A 7, 1974 Hoover et al. (21) Appl. No.: 12/524,522 3,856,606 A 12/1974 Fan et al. 3,867,119 A 2/1975 Kasuga et al. (22) PCT Filed:1-1. Jan. 25, 2007 4,014,7263,911,048 A 10/19753/1977 FargoVargiu et al. 4,028,290 A 6, 1977 Reid (86). PCT No.: PCT/EP2007/050746 4,048,127 A 9/1977 Gibbons et al. S371 (c)(1), (Continued) (2), (4) Date: Nov. 12, 2009 FOREIGN PATENT DOCUMENTS (87) PCT Pub.